![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Multiple Sclerosis |
Free Subscription
1 Hum Immunol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Multiple Sclerosis is free of charge.
Antigen-independent IL-17A production by bystander-activated CD4(+)IL-1R1(+)
cells in patients with multiple sclerosis.
Hum Immunol. 2023 Jan 4:S0198-8859(22)00253-1. doi: 10.1016/j.humimm.2022.
PubMed
Abstract available
Optical coherence tomography reflects clinically relevant gray matter damage in
patients with multiple sclerosis.
J Neurol. 2023 Jan 10. doi: 10.1007/s00415-022-11535.
PubMed
Abstract available
Relation between retina, cognition and brain volumes in MS: a consequence of
asymptomatic optic nerve lesions.
J Neurol. 2023;270:240-249.
PubMed
Abstract available
Decrease of natalizumab drug levels after switching from intravenous to
subcutaneous administration in patients with multiple sclerosis.
J Neurol Neurosurg Psychiatry. 2023 Jan 13:jnnp-2022-330467.
PubMed
Abstract available
Towards a phenotypic understanding of multiple sclerosis depression.
Mult Scler. 2023 Jan 12:13524585221148143. doi: 10.1177/13524585221148143.
PubMed
Pathways between multiple sclerosis, sleep disorders, and cognitive function:
Longitudinal findings from The Nurses' Health Study.
Mult Scler. 2023 Jan 12:13524585221144215. doi: 10.1177/13524585221144215.
PubMed
Abstract available
A neural stem-cell treatment for progressive multiple sclerosis.
Nat Med. 2023 Jan 13. doi: 10.1038/s41591-022-02164.
PubMed
Neural stem cell transplantation in patients with progressive multiple sclerosis:
an open-label, phase 1 study.
Nat Med. 2023 Jan 9. doi: 10.1038/s41591-022-02097.
PubMed
Abstract available
Serum NfL as an MS biomarker.
Nat Rev Neurol. 2023;19:3.
PubMed
Cholesterol pathway associated with MS disability.
Nat Rev Neurol. 2023;19:3.
PubMed
A Cross-Trait, Mendelian Randomization Study to Investigate Whether Migraine Is a
Risk Factor for Multiple Sclerosis.
Neurology. 2023 Jan 11:10.1212/WNL.0000000000206791.
PubMed
Abstract available
Paradigm shifts in multiple sclerosis management: Implications for daily clinical
practice.
Rev Neurol (Paris). 2023 Jan 6:S0035-3787(22)00819.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by